NSE: DRREDDY

Dr. Reddy's: Navigating the Semaglutide Storm and the Path to Resilience

By StreetVantage Intelligence // August 10, 2026

₹₹1,158.80

BULLISH

DISCLAIMER: Educational intelligence only. StreetVantage is NOT SEBI registered. Trading involve risk of loss.